Report Search Results	As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 29) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 9-Feb-10 New Constructs, LLC N/A AUXL: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10     View Abstract 8-Feb-10 Market Edge N/A Market Edge Equity Research Report 4 $10     View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169     View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: AUXILIUM PHARMAC -- AUXL 1 $4     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: AKRX , AOB , AUXL , AVNR , DYAX , IPXL , SCLN , SCMP -- DRUGS 3 $4     View Abstract 5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of AUXILIUM PHARMA INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20     View Abstract 4-Feb-10 Caris & Company James Molloy AUXL (Caris Update)-FDA Approves Xiaflex, Good Label 7 $25     View Abstract 4-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Auxilium Pharmaceuticals, Incorporation 40 $65     View Abstract 2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for AUXL: the economy's impact on AUXL's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15     View Abstract Next 19

Brokerage Reports (Showing 1 to 2 of 2) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 4-Feb-10 Caris & Company James Molloy AUXL (Caris Update)-FDA Approves Xiaflex, Good Label 7 $25     View Abstract 12-Jan-10 Collins Stewart LLC Salveen J. Kochnover CFA Management Meeting; Xiaflex Set for Approval and Launch 5 $10     View Abstract

Independent Reports (Showing 1 to 10 of 27) Release Date  Contributor Author Title Pages Price More Info 9-Feb-10 New Constructs, LLC N/A AUXL: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract 8-Feb-10 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169 View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: AUXILIUM PHARMAC -- AUXL 1 $4 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: AKRX , AOB , AUXL , AVNR , DYAX , IPXL , SCLN , SCMP -- DRUGS 3 $4 View Abstract 5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of AUXILIUM PHARMA INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract 4-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Auxilium Pharmaceuticals, Incorporation 40 $65 View Abstract 2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for AUXL: the economy's impact on AUXL's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract 31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: AUXILIUM PHARMA INC 5 $25 View Abstract Next 17